Fibroblast growth factor 23 in lupus nephritis: A promising biomarker linking renal activity and bone fragility
World Journal of Nephrology · 05.08.2026
DOI: 10.5527/wjn.123610 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Nephrology, online erschienen am 05.08.2026. Verfasst von Lucas Casagrande Passoni Lopes.
Abstract (Originalsprache)
Lupus nephritis (LN) is characterized as one of the main complications of systemic lupus erythematosus (SLE), both in prevalence and severity.Simultaneously, patients with SLE have a high risk of bone fragility due to the integration of different pathophysiological mechanisms.In this context, the identification of biomarkers capable of integrating the duality of renal activity and bone complications of SLE emerges as an important tool for clinical practice.From this perspective, fibroblast growth factor 23 (FGF-23), traditionally known as a regulator of phosphorus and vitamin D metabolism, has emerged as a potential biomarker of the kidney-bone-inflammation axis.In this context, Azoz et al recently published a study in the World Journal of Nephrology reinforces this hypothesis by demonstrating a significant association between elevated FGF-23 levels, poorer renal function, and reduced bone mineral density in patients with LN.Although the observational design limits causal inferences and the exact pathophysiological role of FGF-23 remains incompletely elucidated, such a demonstration points to its potential usefulness as a marker of systemic organ damage in inflammatory conditions such as SLE.
Zitieren
APA
Lopes, L. C. P. (2026). Fibroblast growth factor 23 in lupus nephritis: A promising biomarker linking renal activity and bone fragility. World Journal of Nephrology. https://doi.org/10.5527/wjn.123610
Vancouver
Lopes LCP. Fibroblast growth factor 23 in lupus nephritis: A promising biomarker linking renal activity and bone fragility. World Journal of Nephrology. 2026. doi:10.5527/wjn.123610
BibTeX
@article{Lopes2026,
author = {Lopes, Lucas Casagrande Passoni},
title = {Fibroblast growth factor 23 in lupus nephritis: A promising biomarker linking renal activity and bone fragility},
journal = {World Journal of Nephrology},
year = {2026},
doi = {10.5527/wjn.123610}
}
EUVIMED